StonvexLoading…
StonvexStonvexStonvexCore line items from NTRS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.02B | $4.73B | $4.36B | $4.43B |
Operating Income | $2.34B | $2.66B | $1.46B | $1.77B |
Net Income | $1.74B | $2.03B | $1.11B | $1.34B |
EPS (Diluted) | $8.74 | $9.77 | $5.08 | $6.14 |
Total Assets | $177.13B | $155.51B | $150.78B | $155.04B |
Total Liabilities | $164.17B | $142.72B | $138.89B | $143.78B |
Cash & Equivalents | $5.87B | $4.68B | $4.79B | $4.65B |
Free Cash Flow OCF − CapEx | $5.46B | $-587.50M | $2.51B | $2.26B |
Shares Outstanding | 186.34M | 195.97M | 205.13M | 208.43M |